White Powder Tesamorelin CAS 218949-48-5 treatment powder for bodybuilding

White Powder Tesamorelin CAS 218949-48-5 treatment powder for bodybuilding

1. Quick Detail:

Tesamorelin Sequence

Unit Size :2 mg/vial
Unit Quantity :1 Vial
C6H9O-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-

Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-

NH2
CAS #: 218949-48-5
Molecular Formula:C211H366N72O67S1
Molecular Weight:5135.89
Appearance:white powder
Purity (HPLC):≥98.00%
Manufacture:GC
Packing:as requirments

2. Description:

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a

trans-3-Hexenoic acid group.

Tesamorelin (also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone

which is used in the treatment of HIV-associated lipodystrophy.

p;tendon fibroblasts in a dose-dependent manner as revealed by transwell filter migration assay.

BPC 157 also dose dependently accelerated the spreading of tendon fibroblasts on culture

dishes. The F-actin formation as detected by FITC-phalloidin staining was induced in BPC 157

treated fibroblasts. The protein expression and activation of FAK and paxillin were determined by

Western blot analysis, and the phosphorylation levels of both FAK and paxillin were dose dependently

increased by BPC 157 while the total amounts of protein was unaltered. In conclusion, BPC 157

promotes the ex vivo outgrowth oftendon fibroblasts from tendon explants, cell survival under stress,

and the in vitro migration of tendonfibroblasts, which is likely mediated by the activation of the

FAK-paxillin pathway.

nbsp; was responsible for pituitary stimulation. In 1999 researchers Goa and Prakash checked

sermorelin GH as provocative tasting method for deficiency of endogenous G-hormone.
The most known features of this research compound are increasing lean muscular tissue mass,

reducing fat, increasing bone tissue density and even enhancing functioning of immune system.

It complies with certain amino-segment of natural long-chained GHrh. Sermorelin helps to convert exceeded volume of GH by liver into IGF-1.

3. Applications:

Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases

pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH).

Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive

cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent

conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.

Fat Loss and the Tesamorelin Peptide
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is

clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral

body fat).